Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Viral Vaccines
Sort By
Newest First
1 / 1
1 / 1
License Agreement
Nuance Pharma Announces License and Supply Agreement with Bavarian Nordic on the Development and Commercialization of RSV Vaccine for Adults in China
Nuance Pharma
PR-M03-22-08
Mar 21, 2022
Scale-Up Collaboration
IDT Biologika Collaborates with Exothera to Push Forward the Scale-Up of Viral Vaccines
IDT Biologika
PR-M03-22-01
Mar 01, 2022
CDMO Acquisition
Vibalogics Acquired by Top Global CDMO Recipharm AB
Vibalogics
PR-M02-22-18
Feb 18, 2022
Viral Vaccines
Viral Vectors, Vaccines — A New Era Of Collaborative Design
Andreas Neubert, Ph.D.
IDT Biologika
PAO-10-21-CL-17
Nov 08, 2021
Vaccine Development
The Advantages of Implementing Plant-Based Vaccines
Sylvain Marcel, Ph.D; Robert Erwin; Brian R. Berquist, Ph.D.
iBio, Inc.
PAP-Q3-20-CL-021
Sep 29, 2020
Moderna Highlights Opportunity of mRNA Vaccines
Moderna
PR-M04-20-NI-019
Apr 14, 2020
AAV and LV Vectors
Supporting AAV and Lentiviral Vector Development and Commercialization
James Brown, Ph.D.
Aldevron
PAP-Q2-2019-CL-005
May 24, 2019
Vaccine
Tactiva Therapeutics Announces License to Oncolytic Vaccinia Virus Armed With CXCR4 Antagonist for Treatment of Ovarian Cancer
Tactiva Therapeutics
PR-M11-18-NI-109
Nov 30, 2018
Expansion
Fujifilm Announces The Expansion Of Its Fill Finish Services
Fujifilm Diosynth Biotechnologies
PR-M05-18-NI-095
May 25, 2018
